Infants Exposed to Psychotropic Drugs During Pregnancy At Risk
New research published in the July issue of The Journal of Clinical Psychiatry found that the use of mood stabilizers, antipsychotics, antidepressants, and hypnotics during pregnancy is associated with increased health risks to the infant.
The Good, the Bad, and the Ugly: An Infographic on Bipolar Drugs
Bipolar drug therapy is a balancing act of benefits vs. harms. Odds of attributable benefit cluster in a 15-25% band, so 75%-85% don’t see substantial benefit. Stated differently, if five people take a bipolar drug, only one is likely to see substantial improvement due to it, but all five will have side effects.
”Broken Brains” and “Beautiful Minds”
When I first interviewed Brandon Banks, in the spring of 2008, while researching Anatomy of an Epidemic, he had recently entered Elizabethtown Community College...
In Memory of Julie Greene
With deep regret, Mad in America announces another loss in our contributor community. Julie C. Greene, writer and antipsychiatry advocate, lost her battle with kidney disease on November 29 at her home in Beaver Falls, Pennsylvania. Julie had been an MIA blogger since 2014, including several pieces on the dangers of lithium.
My Response to the FDA’s ECT Rule Change
I lived through forced ECT from 2005-2006 at the Institute of Living in Hartford, Connecticut. My experience with ECT was the impetus for me to become involved in the antipsychiatry and Mad Pride movements, although I am not entirely opposed to voluntary mental health treatment. The following is the comment I submitted to the FDA on its proposal to down-classify the ECT shock device.
Update: Massachusetts Benzodiazepine Bill Hearing
The hearing for Bill H4062: Informed Consent for Benzodiazepines and Non-benzodiazepine Hypnotics took place on Monday – in the middle of an April snowstorm! The discussion clarified some important points in the legislation and gave survivors an opportunity to tell their stories. I was so proud to be there and witness the courage, camaraderie, resilience, advocacy, and vulnerability of fellow survivors. This legislation is our chance to be heard. As one survivor said, through tears, to the committee, “Do not let my suffering be in vain. I beg you to pass this bill.”
Long-term Use of Lithium Can Cause Kidney Failure
A third of patients who have taken the common psychiatric medication lithium for over ten years have developed "chronic renal failure" from the drug.
On Pharma, Corruption, and Psychiatric Drugs
"My studies in this area lead me to a very uncomfortable conclusion: Our citizens would be far better off if we removed all the psychotropic drugs from the market, as doctors are unable to handle them. It is inescapable that their availability creates more harm than good."
- Peter Gøtzsche, MD; Co-founder of the Cochrane Collaboration
Sinead O’Connor Announces: “I’m Not Bipolar . . . I Should Never Have Been...
Singer Sinead O'Connor announced on her website that after several "second opinions" she has learned "I do not in fact suffer from Bi Polar...
Consequences of Taking the Yellow Brick Road: Lithium Carbonate 1984-1996
I was first given Lithium Carbonate in the spring of 1984, and I was taken off Lithium by my attending physician in 1996, but left on other drugs. It took me until 2012 to realize psychiatry is a sham. So often people tell me, “I don’t care what my life is like ten years from now. I only want to feel good now.” I may have said the same thing twenty years ago. Now I have the hindsight to know that my viewpoint back then was juvenile at best. I try to warn other patients these days. It’s hard to joke around about something that kills people.
Lithium: A Survivor’s Guide for Parents
When I was a young adult, I was misdiagnosed with bipolar disorder and placed on lithium. I am 61 years old now, living on the edge of end-stage kidney disease. If I could undo everything, by all means, I would not have taken this drug. It is not safe for anyone at any age.
Antidepressants Associated with Increased Risk for Manic Symptoms
An analysis of medical records in the UK reveals that the use of certain antidepressants for depression is linked to a heightened risk for mania and bipolar disorder. The research, published this week in BMJ Open, found the strongest effect for serotonin reuptake inhibitors (SSRIs) and the antidepressant venlafaxine.
Psychiatry: We Need a Truth and Reconciliation Commission in Mental Health
My name is Leah Harris and I'm a survivor. I am a survivor of psychiatric abuse and trauma. My parents died largely as a result of terrible psychiatric practice. Psychiatric practice that took them when they were young adults and struggling with experiences they didn’t understand. Experiences that were labeled as schizophrenia. Bipolar disorder. My parents were turned from people into permanent patients. They suffered the indignities of forced treatment. Seclusion and restraint. Forced electroshock. Involuntary outpatient commitment. And a shocking amount of disabling heavy-duty psychiatric drugs. And they died young, from a combination of the toxic effects of overmedication, and broken spirits.
Lithium May Cause Sexual Dysfunction — More Research Needed
Lithium appears to reduce libido and sexual function, and more research into the problem is needed.
Psychiatric Drugs: an Increasing Portion of Prescription Costs
Rising prescriptions for psychiatric medications are partly a result of longer-term treatment and increasing population, according to an article by Joanna Moncrieff and Stephen...
Valproate Linked to Decreased Brain Volume in Children Diagnosed with Bipolar Disorder
Researchers find that valproate decreases brain volume in a region associated with emotion processing across all participants.
A Journey Into Madness and Back Again: Part 3
The idea of spending more time as a bureaucrat in the US Embassy in Iceland did not appeal to me. I longed for the freedom that academics have. While pursuing that dream I stumbled into the world of international media, “chemical imbalance”, book publishing and a greedy professor of psychiatry which was a prelude to my second annus horribilis.
People Diagnosed with Bipolar Disorder at Increased Risk for Parkinson’s
Increased Parkinson's risk could be related to lithium, antipsychotic, and antiepileptic drug use.
Study Explores Meanings of Bipolar Disorder to Those Diagnosed
The narratives about Bipolar Disorder promoted by drug companies may influence how those diagnosed understand themselves.
A Rorschach Test for Psych Drugs
On October 23, the New York Times ran a very nice feature story about a Los Angeles woman, Keris Myrick, who, even though she...
Lithium
In this piece for Healing Journey, Anne O'Beirne briefly summarizes the history of the medical usage of lithium and describes the impact that the drug has...
Michael Samuel Bloom
by Chaya Grossberg
July 25, 2012
He also told me the shrinks were changing around his drugs and adding more. They added an antidepressant or two to the Lithium and increased doses and eventually he seemed to have very little life left in him. Our phone calls became trying for he was so down, practically dead sounding a lot of the time, and I felt unable to do anything or say anything to make a difference. To even try felt futile and I wondered if talking to me at all was becoming the burden of yet another person he couldn't connect with.
In the early years, he liked to think of us as being in the same boat, both mentally ill, since I'd also had a meltdown and I also am extremely sensitive and go through extreme states. But as the years went by, especially towards the end, I seemed to be in the ever growing “other” camp in his eyes, which meant I was yet another person who didn't get what it was like to be him. And at that point I can confirm I did not, and perhaps did not want to.
Pfizer Loses Appeal of Neurontin
On Monday the U.S. Supreme Court rejected Pfizer's appeal of a $142 million award to the Kaiser Foundation for illegal marketing of Neurontin. The...
Primary Care Practitioners May Mistake Irritability as Bipolar Disorder in Youth
Family medicine and pediatric providers are less confident in their assessment of irritability in youth than psychiatric providers, which may lead to overdiagnosis of bipolar disorder.
Pfizer to Pay $325M for False Neurontin Marketing
After ten years of litigation, Pfizer has agreed to pay $325 million for marketing its anticonvulsant Neurontin for unapproved purposes. The settlement comes six...